Efficacy and safety of rivaroxaban, colchicine, and famotidine-loratadine with specialist supportive clinical care for fatigue in patients with post-COVID-19 condition in the UK: a multisite, open-label, randomised controlled trial. (linkinghub.elsevier.com)

Journal: Lancet Infectious Diseases Published: 2026-07-08 DOI: https://doi.org/10.1016/S1473-3099(26)00242-2